Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MIRA

Mira Pharmaceuticals Inc

May 29 • 04:00PM ET

1.06

-0.02 -1.85 %

Healthcare • Drug Manufacturers - General • USA • Nano • NASD

Peers: AMRN BGM ASRT CRDL DERM ANIK LFCR TKNO EOLS OPTH

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.44	Insider Own	16.53%	Shs Outstand	42.02M	Perf Week	7.28%
Market Cap	44.54M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	35.08M	Perf Month	3.92%
Enterprise Value	35.13M	PEG	-	EPS next Q	-	Inst Own	5.12%	Short Float	1.16%	Perf Quarter	-16.54%
Income	-31.37M	P/S	-	EPS this Y	-	Inst Trans	-1.89%	Short Ratio	2.51	Perf Half Y	-26.90%
Sales	0.00M	P/B	4.76	EPS next Y	-	ROA	-577.42%	Short Interest	0.41M	Perf YTD	-29.80%
Book/sh	0.22	P/C	4.73	EPS next 5Y	-	ROE	-589.41%	52W High	2.45 -56.73%	Perf Year	-20.90%
Cash/sh	0.22	P/FCF	-	EPS past 3/5Y	-41.42% -211.56%	ROIC	-335.50%	52W Low	0.90 17.78%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.75% 5.52%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-185.37%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	82.16	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	82.16	EPS Q/Q	74.44%	SMA20	5.27%	Beta	1.46	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	2.71%	Rel Volume	0.47	Prev Close	1.08
Employees	2	LT Debt/Eq	0.00	Earnings	Dec 03	SMA200	-18.49%	Avg Volume	162.70K	Price	1.06
IPO	Aug 03, 2023	Option/Short	No / Yes	EPS/Sales Surpr.	10.00% -	Trades		Volume	76,726	Change	-1.85%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)